DCPS as an m7G-Related Biomarker in Diabetic Foot Ulcers: Innovations, Methods, and Implications

Study Background and Research Question

Chronic nonhealing wounds, particularly diabetic foot ulcers (DFU), remain a major complication in diabetes management, affecting up to 34% of adult patients globally. These wounds are characterized by impaired epithelial cell proliferation, defective migration, and persistent inflammation, leading to delayed healing and increased risk of infection or amputation. While the role of epigenetic and RNA modifications in wound repair is increasingly recognized, the precise molecular mechanisms linking RNA methylation to DFU pathogenesis have not been fully elucidated. In this context, Xiao et al. (2025) set out to determine whether N7-methylguanosine (m7G)-related genes, particularly decapping scavenger enzymes, serve as novel biomarkers and regulators of epithelial cell function during DFU.

Key Innovation from the Reference Study

The principal innovation of the study lies in the identification of DCPS (decapping scavenger enzyme) as a hub gene connecting m7G methylation processes to the regulation of epithelial cell proliferation and migration in DFU. Using a combination of differential gene expression analysis, weighted gene coexpression network analysis (WGCNA), and in vitro functional assays, the authors provide robust evidence that DCPS is not only downregulated in DFU tissues but also mechanistically modulates the cell cycle and wound healing capacity of keratinocytes. This work is among the first to systematically link m7G RNA modification machinery to defective epithelial regeneration in chronic wounds, suggesting a new layer of post-transcriptional gene regulation in diabetes complications.

Methods and Experimental Design Insights

The study employed a multi-tiered approach:

• Bioinformatics Analysis: The authors analyzed publicly available DFU transcriptomic datasets to identify differentially expressed genes associated with m7G methylation. WGCNA was used to pinpoint gene modules most correlated with DFU pathology.
• Candidate Selection: Intersection analysis between m7G-related genes and DFU-relevant gene networks yielded DCPS as a top candidate. Diagnostic value was evaluated using receiver operating characteristic (ROC) curves, yielding an area under the curve (AUC) of 0.98–0.99, indicating high discriminatory potential.
• Validation in Human and Mouse Models: DCPS expression was validated by quantitative reverse transcription PCR and immunofluorescence in wound tissues from DFU patients and streptozotocin-induced diabetic mice, both showing significant downregulation compared to controls.
• In Vitro Functional Studies: Normal human epidermal keratinocytes were subjected to DCPS knockdown. Cell proliferation and cell cycle were analyzed by flow cytometry and western blotting; migration was assessed using Transwell and scratch assays; apoptosis was quantified by standard flow cytometric protocols.

Notably, the study leveraged flow cytometry-based cell proliferation assays, which are increasingly favored over traditional methods for their sensitivity and multiplexing capabilities, particularly when paired with click chemistry DNA synthesis detection techniques.

Core Findings and Why They Matter

Core findings from Xiao et al. (2025) are as follows:

• DCPS Downregulation in DFU: Both human and mouse DFU wound tissues exhibit significantly reduced DCPS expression, implicating a conserved role in wound pathophysiology.
• Diagnostic Biomarker Potential: ROC curve analysis demonstrates that DCPS expression discriminates DFU from non-DFU samples with high accuracy, supporting its utility as a molecular biomarker.
• Regulation of Cell Cycle and Proliferation: DCPS knockdown in keratinocytes leads to suppression of cell cycle regulators cyclin D1 and CDK6, decreased S-phase entry, reduced cell proliferation, and increased apoptosis, indicating a mechanistic link between m7G modification and epithelial regeneration.
• Impaired Cell Migration: Loss of DCPS function notably inhibits keratinocyte migration in both Transwell and scratch assays, further contributing to delayed wound closure.

Collectively, these results position DCPS as a key regulator of cell cycle S-phase DNA synthesis measurement and epithelial cell dynamics in the context of diabetic wound repair.

Comparison with Existing Internal Articles

Recent internal reviews (e.g., EdU Flow Cytometry Assay Kits (Cy5): Unraveling Cell Cycle) highlight the value of click chemistry-based DNA synthesis detection in evaluating cell proliferation and cell cycle status. While Xiao et al. (2025) do not explicitly employ EdU incorporation, their reliance on flow cytometry and cell cycle analysis aligns with the utility of such assays in mechanistic studies. Internal articles also emphasize the advantages of copper-catalyzed azide-alkyne cycloaddition (CuAAC) for precise, denaturation-free detection of S-phase cells, which would be directly applicable to validating findings like those presented in this DFU study. Furthermore, the workflow recommendations outlined in internal guides (e.g., Optimizing S-Phase Detection) reinforce the importance of robust, reproducible, and multiplexable approaches for dissecting cell cycle perturbations in disease models.

Protocol Parameters

• DCPS Knockdown: siRNA transfection of keratinocytes, followed by validation of knockdown efficiency by qRT-PCR.
• Cell Proliferation and Cell Cycle Assay: Post-knockdown, keratinocytes subjected to flow cytometry using S-phase DNA synthesis detection protocols; for translational workflows, EdU-based click chemistry assays can be adopted for higher sensitivity.
• Migration Assessment: Cells evaluated using Transwell and scratch assays at specified time points post-transfection to quantify migratory capacity.
• Validation in Animal Models: Wound tissues from diabetic and control mice analyzed for DCPS expression by immunofluorescence and qRT-PCR.

Limitations and Transferability

While the study convincingly links DCPS to cell cycle and migration regulation, several limitations warrant consideration. First, although expression and functional assays were validated in both human and mouse systems, in vivo mechanistic studies—such as rescue experiments or cell-type-specific deletions—were not performed. Second, while cell proliferation and migration were measured in vitro, the complexity of the wound microenvironment, including immune and stromal interactions, was not fully addressed. Finally, the study is focused on epithelial keratinocytes; transferability to other cell types or wound models requires further investigation. The diagnostic and therapeutic relevance of DCPS in broader patient cohorts remains to be validated in future clinical studies.

Research Support Resources

For researchers aiming to replicate or extend these findings, particularly those investigating cell cycle perturbations and proliferation in chronic wound models, the use of advanced flow cytometry cell proliferation assay tools is recommended. The EdU Flow Cytometry Assay Kits (Cy5) (SKU K1078) from APExBIO provide a sensitive, denaturation-free approach for click chemistry DNA synthesis detection, enabling precise quantification of S-phase entry and facilitating multiplex analysis. These kits are well suited to workflows evaluating epithelial cell dynamics, as demonstrated in the reference study. For best practices and troubleshooting, consult the latest internal reviews and methodological guides for integrating copper-catalyzed azide-alkyne cycloaddition (CuAAC) protocols into flow cytometry-based cell proliferation experiments.